Skip to content

    Zen Technologies

    ZENTEC
    Capital Goods·8 May 2026
    Management Summary

    Zen Technologies reported a challenging Q4 FY26 with consolidated revenues declining 45.2% YoY to ₹178.1 crores and EBITDA margin compressing to 28.6%, primarily due to timing of order execution and one-off expenses. However, the company maintains a robust order book of ₹1336 crores, with ₹1000 crores slated for FY27 execution, and remains debt-free with ₹1308 crores in cash. Management highlighted significant new product launches, including the HyperStrike interceptor drone and Vrishabh UGV, and reiterated long-term margin targets, expressing confidence in future growth driven by anti-drone systems and simulators.

    Highlights

    5
    • Consolidated order book of ₹1336 crores as of March 31, 2026, providing clear revenue visibility for FY27.

    • Strong liquidity position with ₹1308 crores in cash and bank balances and a debt-free status.

    • Significant improvement in Days Sales Outstanding (DSO) to 119 days, down 42 days sequentially.

    • Launch of several advanced products including the HyperStrike interceptor drone, Vrishabh UGV, and 30mm smart ammunition, with production for HyperStrike commencing in FY27.

    • Long-term guidance of 35% operational EBITDA and 25% PAT margins remains intact.

    Concerns

    4
    • Q4 FY26 consolidated revenues declined by 45.2% YoY to ₹178.1 crores, impacted by timing of order inflows.

    • Operational EBITDA margin compressed to 28.6% in Q4 FY26, lower by 900 basis points sequentially and 1390 basis points YoY, due to lower revenue base, year-end employee incentives (₹5 crores), increased warranty provisioning (₹3.1 crores), post-supply export expenses (₹2.7 crores), and higher R&D (₹3.3 crores).

    • Working capital days slightly increased to 196 days from 194 days in Q3 FY26, primarily due to higher inventory and advances for FY27 projects.

    • Delay in government order placement for simulators due to 'Operation Sindoor' crisis, which prioritized emergency anti-drone procurement.

    Key financials

    Metrics

    10

    Periods

    2

    Q4 FY26

    5
    • Consolidated Revenue
      ₹178.1 Cr
      YoY-45.2%QoQ+0.2%
    • Operational EBITDA
      ₹51 Cr
    • Operational EBITDA Margin
      28.6%
    • PAT
      ₹47.2 Cr
    • PAT Margin
      26.5%

    FY26

    5
    • Consolidated Revenue
      ₹687.7 Cr
      YoY-29.4%
    • Operational EBITDA
      ₹247.2 Cr
    • Operational EBITDA Margin
      36.0%
    • PAT
      ₹217.9 Cr
    • PAT Margin
      31.7%

    Segment breakdown

    Subsidiaries (FY26)
    ₹260 Cr Revenue
    Standalone (FY26)
    ₹423 Cr Revenue
    ARI (FY26)
    ₹131 Cr Revenue30.3% PAT Margin
    UTS (FY26)
    26.5% PAT Margin
    Other Subsidiaries (FY26)
    ₹10 Cr Revenue
    List

    Order Book

    high confidence

    Total Value

    ₹ 1,336 crores

    as of 2026-03-31

    quantified

    Execution

    Majority of order book scheduled for execution from FY2027 onwards, with Rs.1000 crores expected in FY2027 (mostly Q2 and Q3).

    Composition

    Mix4 subsidiarys
    • ARI (closing order book)₹ 75 crores24.2%
    • UTS (closing order book)₹ 35 crores11.3%
    • ARI (opening order book)₹ 90 crores29.0%
    • UTS (opening order book)₹ 110 crores35.5%

    Share of order book by subsidiary (derived from disclosed amounts)

    Pipeline

    other

    Bidding pipeline for regular tenders may take longer (18 months), but overall pipeline is in thousands of crores.

    "The demand for both simulation and anti-drone segments has far exceeded estimates, leading to a significant increase in expected orders for FY27. The company expects the order book to touch ₹3000 crores at some point."

    Source:
    Prepared remarks

    Capital allocation

    3
    high confidence
    CategoryHeadline
    Capex

    Capex disclosed

    Debt

    Debt disclosed

    Liquidity

    Cash ₹1,308 crores

    Cash and bank balances aggregated to Rs.1308 Crores as of March 31, 2026.

    Guidance & targets

    13
    CategoryTargetPriority
    Revenue
    Consolidated Turnover
    ₹4000 Crores
    High
    Order Book
    Order Book Value
    ₹3000 Crores
    Medium
    Profitability
    Operational EBITDA Margin
    35%
    High
    Profitability
    PAT Margin
    25%
    High
    Subsidiary Revenue
    UTS and ARI combined Revenue
    ₹365 Crores
    High
    Subsidiary Margins
    ARI PAT Margin
    27-30%
    High
    Subsidiary Margins
    UTS PAT Margin
    30-31%
    High
    Working Capital
    Working Capital Days
    140-150 days
    High
    Product Launch
    HyperStrike Interceptor Drone Production
    Production start
    High
    Product Launch
    Vrishabh UGV Commercial Launch
    Commercial launch
    High
    Product Launch
    Weapon Systems Launch
    Launch
    High
    Product Launch
    Ammunition Manufacturing
    Start manufacturing and supplying
    High
    Ammunition Manufacturing
    30mm Ammunition Manufacturing Certification
    Certification and manufacturing start
    High

    Order Book Conversion to Revenue

    FY27
    Current₹1336 crores order book as of March 31, 2026
    Target₹1000 crores revenue from order book in FY27 (mostly Q2 and Q3)

    Why it matters

    This will demonstrate execution capability and validate the revenue visibility for the next fiscal year.

    Most of the order book that we have of 1336 out of that the product which will be dispatched in FY2027 is around Rs.1000 crores. The balance Rs.326 Crores is basically AMC revenue, and AMC revenue gets spread over a period of the AMC contract. So out of the total order book Rs.1000 Crores is expected to be executed and most of the deliveries is going to happen in Q2 and Q3 of FY2027.

    How to verify

    key_financials.metrics[label='Consolidated Revenue (FY27)']

    Risks & concerns

    4
    RiskSeverity

    Delay in government order placement for simulators

    Simulator orders were delayed due to the 'Operation Sindoor' crisis, as government prioritized emergency anti-drone procurement. These orders are now expected soon.Management acknowledged

    medium

    Margin compression in Q4 FY26

    Q4 EBITDA margin compressed due to lower revenue base, year-end employee incentives (₹5 Cr), increased warranty provisioning (₹3.1 Cr), post-supply export expenses (₹2.7 Cr), and higher R&D (₹3.3 Cr). Management believes these are largely one-time or period-specific.Management acknowledged

    medium

    Increased working capital days

    Working capital days increased slightly to 196 days due to higher inventory and advances to suppliers for projects scheduled for FY27 execution. Management expects it to normalize to 140-150 days long-term.Management acknowledged

    low

    Competition from foreign procurement/technology

    Analyst raised concern about foreign procurement component increasing. Management emphasized government's focus on IDDM and the long-term advantage of indigenous design and development.Analyst downplayed

    medium

    Q&A highlights

    7

    “I think the orders will be accelerated now. We expect both the segment, the simulation segment and the anti-drone segment really increasing the size of orders. As I said that the demand which we were expecting has far exceeded the estimate, the reality is much, much, much larger than what we had expected. So, the sustainability of the order is not only sustainable there is going to be a significant increase in the orders that will be received during this year, FY2027.”

    Management confirmed strong order acceleration and reiterated the cumulative ₹4000 crore turnover target for FY27-28, indicating confidence in future growth.

    asked by Mehul Panjwani

    3 min read7 chapters

    Detailed Narrative

    01

    Q4 FY26 Financial Performance Overview

    Zen Technologies reported consolidated revenues of ₹178.1 crores for Q4 FY26, broadly in line with Q3 FY26 (₹177.8 crores) but a significant 45.2% decline year-on-year from Q4 FY25 (₹325 crores). Operational EBITDA for the quarter stood at ₹51 crores, translating to a margin of 28.6%, which was lower by approximately 900 basis points sequentially and 1390 basis points year-on-year. Profit after tax for Q4 FY26 was ₹47.2 crores, with a PAT margin of 26.5%.

    02

    Full Year FY26 Financials and Margin Drivers

    For the full year FY26, consolidated revenues were ₹687.7 crores, a 29.4% decrease from FY25 (₹973.6 crores). Operational EBITDA for FY26 was ₹247.2 crores, with a margin of 35.95%, lower by 240 basis points YoY. The Q4 margin compression was attributed to a lower revenue base, year-end employee incentives (₹5 crores), increased warranty provisioning for anti-drone systems (₹3.1 crores), post-supply export expenses (₹2.7 crores), and higher R&D investments (₹3.3 crores sequentially). Management stated that the long-term guidance of 35% operational EBITDA and 25% PAT margins remains intact.

    03

    Robust Order Book and Execution Visibility

    As of March 31, 2026, the consolidated order book stood at ₹1336 crores, with the standalone order book at ₹1222.6 crores. The majority of this order book, specifically ₹1000 crores, is scheduled for execution in FY27, primarily in Q2 and Q3. The remaining ₹326 crores represents AMC revenue spread over the contract period. Management expressed high confidence in achieving a cumulative turnover of ₹4000 crores for FY27-28 and expects the order book to reach ₹3000 crores at some point.

    04

    Working Capital and Liquidity Position

    Working capital days as of March 31, 2026, were 196 days, a slight increase from 194 days in Q3 FY26, mainly due to higher inventory and advances to suppliers for FY27 projects. However, Days Sales Outstanding (DSO) improved significantly by 42 days, from 161 days in December 2025 to 119 days at FY26 end. The company maintains a strong liquidity position, being debt-free with cash and bank balances aggregating to ₹1308 crores as of March 31, 2026. Management targets a long-term working capital cycle of 140-150 days.

    05

    New Product Launches and Innovation

    Zen Technologies is launching several advanced products, including the HyperStrike interceptor drone, which costs $10,000, flies at 400 km/h, and has AI-enabled tracking. Production for HyperStrike is expected to start this financial year, with a capacity of 5000 units per shift per month, scalable to 15000. Other launches include Vrishabh, an Unmanned Ground Vehicle (UGV) with a 150kg payload and 85%+ indigenous content, planned for commercial launch in FY27, and 30mm smart ammunition, for which manufacturing is expected to start next year after certification. The company also introduced a cyber security suite and a CIWS gun missile system.

    06

    Focus on Anti-Drone Systems and Simulators

    The company highlighted the increasing prominence of anti-drone systems and simulators in recent wars. Their anti-drone system offers hard kill options, wider frequency dominance (70MHz-12GHz), and a 20km radar detection range, positioning it ahead of global competitors. An advanced anti-drone simulator has also been developed. Management noted that the focus on anti-drone systems has almost doubled post the Israel-Iran war, and they expect this segment to be a major contributor to future turnover, with a 55-45 split favoring anti-drone systems in the pipeline.

    07

    Subsidiary Performance and Outlook

    In FY26, subsidiaries contributed ₹260 crores to consolidated revenue, with ARI (acquired end of FY25) contributing ₹131 crores at a PAT margin of 30.3%, and UTS contributing the remaining with a PAT margin of 26.5%. Other subsidiaries added ₹10 crores. For FY27, UTS and ARI combined are projected to achieve ₹365 crores in revenue, with ARI maintaining 27-30% margins and UTS 30-31% margins. The closing order book for ARI and UTS as of March 31, 2026, was ₹75 crores and ₹35 crores, respectively.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.